Latest news
Lexicon Pharmaceuticals (NASDAQ:LXRX) Announces Earnings Results, Misses Estimates By $0.01 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 03:08:57 GMTWhy Lexicon Pharmaceuticals (LXRX) Is Up 6.9% After Q2 Revenue Collapse And New Shelf Filings - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 00:15:00 GMTLexicon Pharmaceuticals Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:03:57 GMTFMR LLC (LXRX) discloses 11.7% Lexicon Pharmaceuticals stake in amended 13G - Stock TitanStock Titan · Thu, 06 Aug 2026 14:32:36 GMTLexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:50:10 GMTLexicon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:32:50 GMTLexicon: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 11:56:51 GMTLexicon Pharma (Nasdaq: LXRX) swings to $31.8M Q2 2026 loss - Stock TitanStock Titan · Thu, 06 Aug 2026 11:33:50 GMT